169 related articles for article (PubMed ID: 22901392)
1. A novel aminopeptidase N inhibitor developed by virtual screening approach.
Feng J; Jin K; Zhu H; Zhang X; Zhang L; Liu J; Xu W
Bioorg Med Chem Lett; 2012 Sep; 22(18):5863-9. PubMed ID: 22901392
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.
Su L; Jia Y; Zhang L; Xu Y; Fang H; Xu W
Bioorg Med Chem; 2012 Jun; 20(12):3807-15. PubMed ID: 22607877
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors.
Yang K; Fen J; Fang H; Zhang L; Gong J; Xu W
J Enzyme Inhib Med Chem; 2012 Apr; 27(2):302-10. PubMed ID: 21770859
[TBL] [Abstract][Full Text] [Related]
4. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Li Q; Fang H; Wang X; Hu G; Wang Q; Xu W
Bioorg Med Chem Lett; 2012 Jan; 22(2):850-3. PubMed ID: 22206607
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.
Pan H; Yang K; Zhang J; Xu Y; Jiang Y; Yuan Y; Zhang X; Xu W
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):717-26. PubMed ID: 22545941
[TBL] [Abstract][Full Text] [Related]
6. Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.
Zhang X; Fang H; Zhu H; Wang X; Zhang L; Li M; Li Q; Yuan Y; Xu W
Bioorg Med Chem; 2010 Aug; 18(16):5981-7. PubMed ID: 20637634
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
[TBL] [Abstract][Full Text] [Related]
8. Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN).
Jin K; Zhang X; Ma C; Xu Y; Yuan Y; Xu W
Bioorg Med Chem; 2013 May; 21(9):2663-70. PubMed ID: 23510562
[TBL] [Abstract][Full Text] [Related]
9. Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Ma C; Cao J; Liang X; Huang Y; Wu P; Li Y; Xu W; Zhang Y
Eur J Med Chem; 2016 Jan; 108():21-27. PubMed ID: 26629857
[TBL] [Abstract][Full Text] [Related]
10. Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.
Jia M; Yang K; Fang H; Xu Y; Sun S; Su L; Xu W
Bioorg Med Chem; 2011 Sep; 19(17):5190-8. PubMed ID: 21802307
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.
Zhang X; Zhang J; Zhang L; Feng J; Xu Y; Yuan Y; Fang H; Xu W
Bioorg Med Chem; 2011 Oct; 19(20):6015-25. PubMed ID: 21911297
[TBL] [Abstract][Full Text] [Related]
12. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of small-molecule fluorescent photoprobes targeted to aminopeptdase N (APN/CD13) for optical imaging of angiogenesis.
Hahnenkamp A; Schäfers M; Bremer C; Höltke C
Bioconjug Chem; 2013 Jun; 24(6):1027-38. PubMed ID: 23642127
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
15. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I.
Li Q; Fang H; Wang X; Hu L; Xu W
Eur J Med Chem; 2009 Dec; 44(12):4819-25. PubMed ID: 19683842
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
[TBL] [Abstract][Full Text] [Related]
17. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
18. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Ma C; Jin K; Cao J; Zhang L; Li X; Xu W
Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219
[TBL] [Abstract][Full Text] [Related]
19. Engineered Thermoplasma acidophilum factor F3 mimics human aminopeptidase N (APN) as a target for anticancer drug development.
Su J; Wang Q; Feng J; Zhang C; Zhu D; Wei T; Xu W; Gu L
Bioorg Med Chem; 2011 May; 19(9):2991-6. PubMed ID: 21493078
[TBL] [Abstract][Full Text] [Related]
20. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
